Table 3. Multivariate analysis of prognostic factors identified in our study with DFS as the end point in patients with NSCLC.

Prognostic factor	HR1	95% CI2	P-value3
pTNM stage
I vs. II+III	0.095	0.030–0.303	<0.001
miR-155-5p
Low vs. high	0.060	0.005–0.767	0.030
miR-223-3p
Low vs. high	1.449	0.581–3.614	0.426
miR-20a-5p
Low vs. high	2.881	1.009–8.227	0.048
miR-152-3p
High vs. low	0.333	0.125–0.892	0.029
miR-126-3p
High vs. low	0.497	0.191–1.295	0.153
miR-199a-5p
High vs. low	0.204	0.045–0.918	0.038

¹HR; hazard ratio.–²CI; confidence interval. ³ P-value<0.05 statistically significant.